Decreasing initial hospitalization of the cyclosporine-treated renal allograft recipient is safe

Transplant Proc. 1988 Jun;20(3 Suppl 3):204-6.
No abstract available

MeSH terms

  • Costs and Cost Analysis
  • Cyclosporins / therapeutic use*
  • Hospitalization / economics*
  • Humans
  • Immunosuppression Therapy / economics
  • Kidney Transplantation*
  • Postoperative Care
  • Time Factors

Substances

  • Cyclosporins